Immunologic responses to gene transfer into mice via the polymeric immunoglobulin receptor

Gene Therapy

Volumn 3, Issue 8, 1996, Pages 669-678

  Ferkol, T ^a,b   Pellicena Palle, A ^a   Eckman, E ^a   Perales, J C ^b,c   Trzaska, T ^a   Tosi, M ^a   Redline, R ^c   Davis, P B ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Copernicus Gene Systems ^*  (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene transfer; Immune response; Polymeric immunoglobulin receptor; Secretory component

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN RECEPTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; HUMORAL IMMUNITY; IMMUNOGENICITY; LIVER; MOUSE; NONHUMAN; PLASMID; POLYMERIZATION; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; TARGET ORGAN; TRANSGENE;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; BLOOD CHEMICAL ANALYSIS; COMPLEMENT ACTIVATION; DNA; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FAB FRAGMENTS; INFLAMMATION; INFUSIONS, INTRAVENOUS; LIVER; LUCIFERASES; MICE; MICE, INBRED C57BL; RATS; RECEPTORS, POLYMERIC IMMUNOGLOBULIN;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0029761375     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Rosenfeld MA et al. in vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143-155.
2. Crystal RG et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994; 8: 42-51.
3. Yoshimura K et al. Expression of the human cystic fibrosis transmembrane conductance regulator gene in a mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucleic Acids Res 1992; 20: 3233-3240.
4. Hyde S et al. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 1993; 362: 250-255.
5. Alton EWFW et al. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet 1993; 5: 135-142.
6. Ferkol T, Kaetzel CS, Davis PB. Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor. J Clin Invest 1993; 92: 2394-2400.
7. Ferkel T et al. Gene transfer into airways in animals by targeting the polymeric immunoglobulin receptor. J Clin Invest 1995; 95: 493-502.
8. Smith TAG et al. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 1993; 5: 397-402.
9. Snouwaert JN et al. An animal model for cystic fibrosis made by gene targeting. Science 1992; 257: 1083-1088.
10. Zeiher BG et al. A mouse model for the ΔF508 allele of cystic fibrosis. J Clin Invest 1995; 95: 2051-2064.
11. Colledge WH et al. Generation and characterization of a ΔF508 cystic fibrosis mouse model. Nat Genet 1995; 10: 445-452.
12. Piskurich JF et al. Molecular cloning of the mouse polymeric Ig receptor: functional regions of the molecule are conserved among five mammalian species. J Immunol 1995; 154: 1735-1742.
13. Mariassy AT. Epithelial cells of the trachea and bronchi. In: Parent RA (ed). Treatise on Pulmonary Toxicology. CRC Press: Boca Raton, 1992, pp 63-76.
14. Rent R, Ertel N, Eisenstein R, Gerwurz H. Complement activation by interaction of polyanions and polycations: heparinprotamine induced consumption of complement. J Immunol 1975; 114: 120-124.
15. Chonn A, Cullis PR, Devine DV. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J Immunol 1991; 146: 4234-4241.
16. Cunningham C et al. Activation of human complement by liposomes: a model for membrane activation of the alternative pathway. J Immunol 1979; 122: 1237-1242.
17. Darquay S, Puryo ME, Capro F, Reach G. Complement activation by algenate polylysine microcapsules used for islet transplantation. Art Organs 1994; 18: 898-903.
18. DeVos P, Wolters GHJ, Fritschy WM, van Schelfgaarde R. Obstacles in the application of microcapsules in islet transplantation. Int J Artif Organs 1993; 16: 205-212.
19. Wilson JM et al. Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low-density lipoprotein receptor-deficient rabbits. J Biol Chem 1992; 267: 963-967.
20. Stankovics J et al. Overexpression of human methylmalonyl coA mutase in mice after in vivo gene transfer with asialoglycoprotein/polylysine/DNA complexes. Hum Gene Ther 1994, 5: 1095-1104.
21. Talan DA. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers. Ann Emerg Med 1993; 22: 1871-1890.
22. Pietersz GA, Rowland A, Smythe MJ, McKenzie IFC. Chemoimmunoconjugates for the treatment of cancer. Adv Immunol 1994; 56: 301-387.
23. Koppell GA. Recent advances with monoclonal antibody drug targeting for treatment of human cancer. Bioconj Chem 1991; 1: 13-23.
24. Smith TW, Yaber E, Yeatman L, Butler VP. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. New Engl J Med 1976; 294: 797-800.
25. Smith TW. Review of clinical experience with digoxin immune Fab (ovine). Am J Emerg Med 1991; 9 (Suppl.): 1-6.
26. The Digibind Study Advisory Panel. Allergic histories and reactions of patients treated with digoxin immune Fab (ovine) antibody. Am J Emerg Med 1991; 9 (Suppl.): 7-10.
27. Pentel PR et al. Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats. Drug Metab Dispos 1988; 16: 141-145.
28. Pentel PR et al. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship. Drug Metab Dispos 1991; 19: 24-28.
29. McClurkan MB, Valentine JL, Arnold L, Owens SM. Disposition of a monoclonal anti-phencyclidine Fab fragment of immnunoglobulin G in rats. J Pharmacol Exp Ther 1993; 266: 1439-1445.
30. Brunn GJ, Keyler DE, Pond SM, Pentel PR. Reversal of desipramine toxicity in rats using drug-specific antibody Fab' fragment: effects on hypotension and interaction with sodium bicarbonate. J Pharmacol Exp Ther 1991; 260: 1392-1399.
31. Kantor FS, Ojeda A, Benacerraf B. Studies on artificial antigens: antigenicity of DNP-polylysine and DNP copolymer of lysine and glutamic acid in guinea pigs. J Exp Med 1962; 117: 55-69.
32. Cochrane CB, Koffler D. Immune complex disease in experimental animals and man. Adv Immunol 1963; 16: 185-264.
33. Gerard NP, Gerard C. The chemotactic factor for human C5a anaphylatoxin. Nature 1991; 349: 614-617.
34. Rollins T, Springer MS. Identification of the polymorphonuclear leukocyte C5a receptor. J Biol Chem 1985; 260: 7157-7160.
35. Fournie GJ, Lambert PH, Meischer PA. Features of the immune response to DNA in mice: genetic control. Clin Exp Immunol 1976; 26: 46-51.
36. Fournie GJ, Lambert PH, Bankhurst AD, Meischer PA. Features of the immune response to DNA in mice: participation of B and T cells. Clin Exp Immunol 1976; 26: 52-56.
37. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med 1995; 1: 890-893.
38. Perales JC et al. Gene transfer in vivo: sustained expression and regulation of genes introduced into the livers by receptor targeted uptake. Proc Natl Acad Sci USA 1994; 91: 4086-4090.
39. Maniatis T, Frisch EF, Stambrook J (eds). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, 1989.
40. Brasier AR, Tate JE, Habener JF. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 1989; 7: 1116-1122.
41. Zar JH (ed). Biostatistical Analysis. Prentice-Hall, Englewood Cliffs: New Jersey, 1974.